EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Catheter Ablation Is Associated With a Decrease in Major Adverse Cardiovascular Events and All‐Cause Mortality in Patients With Atrial Fibrillation and Obstructive Sleep Apnea

Ghassan Bidaoui iD, Christian Massad iD, Joe Abi-Rached, Ahmed Abdelmaksoud, Eman Toraih, Michel Abou-Khalil, Mayana Bsoul iD, Montaser Atasi iD, Amitabh Pandey, Nassir Marrouche iD, and other members of the TRIAD Team, Yara Menassa und 5 weitere

Journal of Cardiovascular Electrophysiology · 2026

DOI: 10.1111/jce.70152 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Ghassan Bidaoui und 16 weiteren Autor:innen. Beteiligte Einrichtung: Tulane Research Innovation for Arrhythmia Discovery, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Sleep Apnea, Obstructive, Catheter Ablation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Obstructive sleep apnea (OSA) is a common risk factor for the development and progression of atrial fibrillation (AF). Whether catheter ablation for AF management in patients with coexisting OSA yields survival benefit remains unclear. This study aimed to assess the association of catheter ablation with the incidence of major cardiovascular events (MACE) and all‐cause mortality in patients with AF and OSA.

Methods

This was a retrospective cohort study using the TriNetX electronic health record (EHR) database, a global, federated clinical research network aggregating de‐identified patient data from multiple healthcare organizations. The study was conducted using real‐world data collected from community‐based healthcare institutions contributing to the TriNetX network. This multicenter, population‐based dataset includes both primary care and referral center data from across the United States and internationally. Adult patients diagnosed with both AF and OSA between November 2014 and November 2024 were included. Patients entered the study at the time of AF diagnosis, with follow‐up beginning 3 months later. A total of 18,324 patients were included after 1:1 propensity score matching, 9162 who underwent catheter ablation and 9162 who did not. Matching was performed based on over 30 clinical and demographic variables, including age, sex, body mass index, comorbidities, medications (e.g., anticoagulation), CPAP prescription, echocardiographic data, and laboratory values. Participants were selected using a convenience sampling method from those available in the database, with inclusion contingent on complete data and fulfillment of eligibility criteria. Data on refusals or exclusions were not available due to the nature of de‐identified secondary EHR data.

Results

Over a median follow‐up of 807 days, 687 MACE events and 438 all‐cause mortality events were recorded. Catheter ablation was associated with a significantly reduced risk of MACE (HR: 0.596, 95% CI: 0.510–0.697) and all‐cause mortality (HR: 0.264, 95% CI: 0.208‐0.335). It was also associated with reduced risk of specific cardiovascular outcomes, including heart failure (HR: 0.376, 95% CI: 0.283–0.501), cerebrovascular disease (HR: 0.492, 95% CI: 0.348–0.696), and cerebral infarction (HR: 0.390, 95% CI: 0.207‐0.733).

Conclusion

Catheter ablation in patients with AF and OSA is associated with a reduced risk of MACE, all‐cause mortality, heart failure, and thromboembolic events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationSleep Apnea, ObstructiveCatheter AblationHumansMaleFemaleMiddle AgedRetrospective StudiesAgedRisk AssessmentTreatment OutcomeTime FactorsDatabases, FactualUnited StatesRisk FactorsProtective FactorsCause of DeathIncidenceElectronic Health Records

Stichwörter der Autor:innen

all‐cause mortalityatrial fibrillationcatheter ablationmajor cardiovascular eventsobstructive sleep apnea

Autor:innen und Institutionen

  • Tulane Research Innovation for Arrhythmia Discovery, New Orleans, Louisiana, USA.

ORCID-Profile: Ghassan Bidaoui, Christian Massad, Mayana Bsoul, Montaser Atasi, Nassir Marrouche

Zitieren

APA

Bidaoui, G., Massad, C., Abi-Rached, J., Abdelmaksoud, A., Toraih, E., Abou-Khalil, M., Bsoul, M., Atasi, M., Pandey, A., Marrouche, N., and other members of the TRIAD Team, Menassa, Y., Feng, H., Rao, S., Lim, C., Assaf, A., & Younes, H. (2026). Catheter Ablation Is Associated With a Decrease in Major Adverse Cardiovascular Events and All‐Cause Mortality in Patients With Atrial Fibrillation and Obstructive Sleep Apnea. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70152

Vancouver

Bidaoui G, Massad C, Abi-Rached J, Abdelmaksoud A, Toraih E, Abou-Khalil M, et al. Catheter Ablation Is Associated With a Decrease in Major Adverse Cardiovascular Events and All‐Cause Mortality in Patients With Atrial Fibrillation and Obstructive Sleep Apnea. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70152

BibTeX
@article{Bidaoui2026,
  author = {Bidaoui, Ghassan and Massad, Christian and Abi-Rached, Joe and Abdelmaksoud, Ahmed and Toraih, Eman and Abou-Khalil, Michel and Bsoul, Mayana and Atasi, Montaser and Pandey, Amitabh and Marrouche, Nassir and and other members of the TRIAD Team, and other members of the TRIAD Team and Menassa, Yara and Feng, Han and Rao, Swati and Lim, Chanho and Assaf, Ala' and Younes, Hadi},
  title = {Catheter Ablation Is Associated With a Decrease in Major Adverse Cardiovascular Events and All‐Cause Mortality in Patients With Atrial Fibrillation and Obstructive Sleep Apnea},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  doi = {10.1111/jce.70152}
}
Kostenlos starten →